Literature DB >> 7512219

Chromosome aberrations in nuclear power plant workers: the influence of dose accumulation and lymphocyte life-time.

H Braselmann1, E Schmid, M Bauchinger.   

Abstract

Chromosome analyses were performed in blood lymphocytes of 22 nuclear power plant workers with a mean accumulated radiation dose of 390 mSv (270-530 mSv). Nineteen workers had received 300 mSv 4-16 years prior to sampling. The frequency of dicentrics and ring chromosomes (1.75 x 10(-3)) was significantly elevated as compared to a control group (0.58 x 10(-3)). Based on the initial slope of an in vitro 60Co gamma-ray curve, a biological dose estimate of only 110 mSv was derived. This can be interpreted in terms of an "equivalent-acute" dose at the time of blood sampling which can be derived by weighting annual doses during working periods of 12-30 years for a mean life-time m of lymphocytes. The annual doses were additionally weighted for a uniform distribution during a whole year. Using m = 10 years, a mean "equivalent-acute" dose of 90 mSv (64-157 mSv) is obtained, which compares more closely to the biologically estimated dose than 20 mSv (7-71 mSv) based on m = 4.3 years.

Mesh:

Substances:

Year:  1994        PMID: 7512219     DOI: 10.1016/0027-5107(94)90031-0

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

1.  Radiobiological shot noise explains Three Mile Island biodosimetry indicating nearly 1,000 mSv exposures.

Authors:  Aaron M Datesman
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

2.  Chromosome Damage in Relation to Recent Radiation Exposure and Radiation Quality in Nuclear Power Plant Workers.

Authors:  Yang Jee Kim; Joong Won Lee; Yoon Hee Cho; Young Joo Choi; Younghyun Lee; Hai Won Chung
Journal:  Toxics       Date:  2022-02-18

3.  Utilization of DNA-protein cross-links as a biomarker of chromium exposure.

Authors:  A Zhitkovich; V Voitkun; T Kluz; M Costa
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.